| Probiotics, their health benefits and applications for developing healthier foods: a review R Nagpal, A Kumar, M Kumar, PV Behare, S Jain, H Yadav FEMS Microbiology Letters, 2012 | 632 | 2012 |
| Cholesterol Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases M Kumar, R Nagpal, R Kumar, R Hemalatha, V Verma, A Kumar, ... Experimental Diabetes Research, 2012 | 617 | 2012 |
| Bioactive peptides derived from milk proteins and their health beneficial potentials: an update R Nagpal, P Behare, R Rana, A Kumar, M Kumar, S Arora, F Morotta, ... Food & function 2 (1), 18-27, 2011 | 366 | 2011 |
| Anti-inflammatory treatments for chronic diseases: a review D Laveti, M Kumar, R Hemalatha, R Sistla, V Gm Naidu, V Talla, V Verma, ... Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets …, 2013 | 362 | 2013 |
| Effect of probiotic (VSL# 3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers and gut colonization in overweight adults: a randomized, controlled trial. H Rajkumar, N Mahmood, M Kumar, SR Varikuti | 330 | 2014 |
| Environmental endocrine-disrupting chemical exposure: role in non-communicable diseases M Kumar, DK Sarma, S Shubham, M Kumawat, V Verma, A Prakash, ... Frontiers in public health 8, 553850, 2020 | 315 | 2020 |
| Probiotic metabolites as epigenetic targets in the prevention of colon cancer M Kumar, R Nagpal, V Verma, A Kumar, N Kaur, R Hemalatha, S Gautam, ... Nutrition reviews, 2013 | 213 | 2013 |
| Molecular approaches for identification and characterization of lactic acid bacteria D Mohania, R Nagpal, M Kumar, A Bhardwaj, M Yadav, S Jain, F Marotta, ... Journal of digestive diseases 9 (4), 190-198, 2008 | 199 | 2008 |
| Polycystic ovary syndrome: etiology, current management, and future therapeutics S Singh, N Pal, S Shubham, DK Sarma, V Verma, F Marotta, M Kumar Journal of Clinical Medicine 12 (4), 1454, 2023 | 174 | 2023 |
| Futuristic non-antibiotic therapies to combat antibiotic resistance: A review M Kumar, DK Sarma, S Shubham, M Kumawat, V Verma, PB Nina, D Jp, ... Frontiers in microbiology 12, 609459, 2021 | 166 | 2021 |
| Effect of Probiotic Lactobacillus salivarius UBL S22 and Prebiotic Fructo-oligosaccharide on Serum Lipids, Inflammatory Markers, Insulin Sensitivity, and Gut … H Rajkumar, M Kumar, N Das, SN Kumar, HR Challa, R Nagpal Journal of cardiovascular pharmacology and therapeutics 20 (3), 289-298, 2015 | 152 | 2015 |
| Milk, milk products and disease free health: an updated overview R Nagpal, PV Behare, M Kumar, D Mohania, M Yadav, S Jain, S Menon, ... Critical Reviews in Food Science and Nutrition 52 (4), 2012 | 147 | 2012 |
| Probiotic Lactobacillus rhamnosus GG and Aloe vera gel improve lipid profiles in hypercholesterolemic rats M Kumar, S Rakesh, R Nagpal, R Hemalatha, A Ramakrishna, ... Nutrition, 2013 | 144 | 2013 |
| Anticarcinogenic effect of probiotic fermented milk and chlorophyllin on aflatoxin-B1-induced liver carcinogenesis in rats M Kumar, V Verma, R Nagpal, A Kumar, PV Behare, B Singh, ... British Journal of Nutrition 107 (1), 1006-1016, 2011 | 131 | 2011 |
| Gut microbiota in health and disease: an overview focused on metabolic inflammation R Nagpal, M Kumar, AK Yadav, R Hemalatha, H Yadav, F Marotta, ... Beneficial microbes 7, 181-194, 2016 | 120 | 2016 |
| Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during AFB1-induced hepatocellular carcinoma M Kumar, V Verma, R Nagpal, A Kumar, SK Gautam, PV Behare, ... Gene 490 (1-2), 54-59, 2011 | 111 | 2011 |
| Fortification and fermentation of fruit juices with probiotic Lactobacilli R Nagpal, A Kumar, M Kumar Annals of Microbiology, 2012 | 94 | 2012 |
| Exopolysaccharides of Lactic Acid Bacteria- a review PV Behare, R Singh, M Kumar, RP Singh, JB Prajapati J Food Sci Technol 46 (1), 1-11, 2009 | 78 | 2009 |
| Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects M Kumar, AK Yadav, V Verma, B Singh, G Mal, R Nagpal, R Hemalatha Future microbiology 11 (4), 585-600, 2016 | 75 | 2016 |
| Mucormycosis in COVID-19 pandemic: Risk factors and linkages M Kumar, DK Sarma, S Shubham, M Kumawat, V Verma, B Singh, ... Current Research in Microbial Sciences 2, 100057, 2021 | 74 | 2021 |
Ravinder Nagpal, MSc, PhDDirector, The Gut Biome Lab, Florida State UniversityDirección de correo verificada de fsu.edu
